Omada Health earnings on deck: GLP-1 strategy in focus By Investing.com

Omada Health is set to report its second-quarter earnings, with investors focusing on its strategy to leverage the growing GLP-1 weight-loss medication market. The company is positioning itself as a "GLP-1 gatekeeper" for employers managing costs and has shown strong revenue growth and margin expansion, despite remaining loss-making. Recent partnerships and improved cost discipline from the first quarter suggest potential for sustained membership growth and a viable business model.